Stock Events

Stock Events

GSK 

€43.80
11893
-€0.60-1.35%Tuesday 07:00

Statistics

Day High
0
Day Low
0
52W High
51.5
52W Low
39.8
Volume
0
Avg. Volume
0
Mkt Cap
87.75B
P/E Ratio
-
Dividend Yield
3.68%
Dividend
1.61

Upcoming

Dividends

3.68%Dividend Yield
Oct 2026
€0.40
Jul 2026
€0.40
Apr 2026
€0.41
Jan 2026
€0.37
Oct 2025
€0.37
10Y Growth
-4.29%
5Y Growth
-7.36%
3Y Growth
7.67%
1Y Growth
7.33%

Earnings

Feb 3Expected
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
0.27
0.4
0.52
0.65
Expected EPS
0.3341275082928
Actual EPS
N/A

Financials

2%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
37.95BRevenue
760.68MNet Income

Analyst Ratings

$42.42Average Price Target
The highest estimate is ⁦42.42⁩.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GS70.MU. It's not an investment recommendation.
Legal & General Group
3247
LGEN.LSE
BP
2676
BP.LSE
National Grid
2482
NG.LSE
Aviva
2192
AV.LSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a direct competitor in the pharmaceuticals sector, competing in various therapeutic areas including vaccines.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson competes with GSK in both pharmaceuticals and consumer health products.
Merck
MRK
Mkt Cap368.89B
Merck & Co. is a competitor in the pharmaceuticals industry, with a strong presence in vaccines and cancer treatments.
Novartis
NVS
Mkt Cap303.67B
Novartis competes with GSK in multiple areas including respiratory and neuroscience.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie competes in the biopharmaceutical sector, with overlap in immunology and oncology areas.
Sanofi
SNY
Mkt Cap106.24B
Sanofi competes directly with GSK in the vaccines market and other pharmaceutical areas.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca competes in various pharmaceutical areas including respiratory, cardiovascular, and oncology, similar to GSK.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb competes in the pharmaceutical sector, particularly in cancer and cardiovascular diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes in pharmaceuticals and diagnostics, with a strong focus on oncology and immunology.
AMGEN
AMGN
Mkt Cap251.94B
Amgen competes in the biotech sector, with products that overlap with GSK’s offerings in areas like bone health and oncology.

About

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Show More
CEO
Luke Victor Miels
Employees
66841
Country
United Kingdom
ISIN
US37733W2044
WKN
000A3DMHS

Listings

MX
MX
GSKN.MX
MX
MX
GSK1N.MX
XETRA
DE
GS71.XETRA
STU
DE
GS71.STU

0 Comments

Share your thoughts

FAQs

What is GSK stock price today?▼
The current price of GS70.MU is €43.80 EUR — it has decreased by -1.35% in the past 24 hours. Watch GSK stock price performance more closely on the chart.
What is GSK stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange GSK stocks are traded under the ticker GS70.MU.
Is GSK stock price growing?▼
GS70.MU stock has fallen by -4.78% compared to the previous week, the month change is a +3.79% rise, over the last year GSK has showed a +8.42% increase.
What is GSK market cap?▼
Today GSK has the market capitalization of 87.75B
When is the next GSK earnings date?▼
GSK is going to release the next earnings report on February 3, 2027.
What were GSK earnings last quarter?▼
GS70.MU earnings for the last quarter are 0.65 EUR per share, whereas the estimation was 0.6 EUR resulting in a +8.46% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is GSK revenue for the last year?▼
GSK revenue for the last year amounts to 37.95B EUR.
What is GSK net income for the last year?▼
GS70.MU net income for the last year is 760.68M EUR.
Does GSK pay dividends?▼
Yes, GS70.MU dividends are paid quarterly. The last dividend per share was 0.4 . As of today, Dividend Yield (FWD)% is 3.68%.
How many employees does GSK have?▼
As of November 4, 2026, the company has 66,841 employees.
In which sector is GSK located?▼
GSK operates in the Health & Wellness sector.
When did GSK complete a stock split?▼
The last stock split for GSK was on July 19, 2022 with a ratio of 4:5.
Where is GSK headquartered?▼
GSK is headquartered in London, United Kingdom.